Full Press Release Details
Extension Study Data Supporting Long-Term Safety and Efficacy of Eloctate® Published in Haemophilia.
BIIB
Extension Study Data Supporting Long-Term Safety and Efficacy of Eloctate® Published in Haemophilia
Key Takeaway: Extension Study Data Supporting Long-Term Safety and Efficacy of Eloctate® Published in Haemophilia
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis